Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Goodnow

Showing results (21-30 of 187) with videos related to

Pageof 19
Sort By:
Current Opinion in Immunology|August 8, 2006
ENU-mutagenesis: insight into immune function and pathologyMatthew C Cook, Carola G Vinuesa, Christopher C Goodnow
The Journal of Experimental Medicine|January 23, 2013
Helios marks strongly autoreactive CD4+ T cells in two major waves of thymic deletion distinguished by induction of PD-1 or NF-κBStephen R Daley, Daniel Y Hu, Christopher C Goodnow
Nature Immunology|May 13, 2003
Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signalingLixin Rui, Carola G Vinuesa, Julie Blasioli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiationLixin Rui, James I Healy, Julie Blasioli, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2025
Reply to Bousdar et al.: Common inherited loss-of-function mutations in the innate sensor <i>NOD2</i> contribute to exceptional immune response to cancer immunotherapyMegan B Barnet, Katherine J L Jackson, Christopher C Goodnow
Blood|July 27, 2016
Inhibiting TLR9 and other UNC93B1-dependent TLRs paradoxically increases accumulation of MYD88L265P plasmablasts in vivoJames Q Wang, Bruce Beutler, Christopher C Goodnow, et al.
The Journal of Experimental Medicine|October 23, 2002
Analysis of an ethylnitrosourea-generated mouse mutation defines a cell intrinsic role of nuclear factor kappaB2 in regulating circulating B cell numbersLisa A Miosge, Julie Blasioli, Mathieu Blery, et al.
The Journal of Experimental Medicine|June 15, 2016
Clonal redemption of autoantibodies by somatic hypermutation away from self-reactivity during human immunizationJoanne H Reed, Jennifer Jackson, Daniel Christ, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2010
Consequences of increased CD45RA and RC isoforms for TCR signaling and peripheral T cell deficiency resulting from heterogeneous nuclear ribonucleoprotein L-like mutationZuopeng Wu, Adele L Yates, Gerard F Hoyne, et al.
Plos One|November 11, 2011
Differential requirement for the CD45 splicing regulator hnRNPLL for accumulation of NKT and conventional T cellsMehmet Yabas, Dale I Godfrey, Christopher C Goodnow, et al.
Pageof 19

Showing results (21-30 of 187) with videos related to

Sort By:
Pageof 19
Current Opinion in Immunology|August 8, 2006
ENU-mutagenesis: insight into immune function and pathologyMatthew C Cook, Carola G Vinuesa, Christopher C Goodnow
The Journal of Experimental Medicine|January 23, 2013
Helios marks strongly autoreactive CD4+ T cells in two major waves of thymic deletion distinguished by induction of PD-1 or NF-κBStephen R Daley, Daniel Y Hu, Christopher C Goodnow
Nature Immunology|May 13, 2003
Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signalingLixin Rui, Carola G Vinuesa, Julie Blasioli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiationLixin Rui, James I Healy, Julie Blasioli, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2025
Reply to Bousdar et al.: Common inherited loss-of-function mutations in the innate sensor <i>NOD2</i> contribute to exceptional immune response to cancer immunotherapyMegan B Barnet, Katherine J L Jackson, Christopher C Goodnow
Blood|July 27, 2016
Inhibiting TLR9 and other UNC93B1-dependent TLRs paradoxically increases accumulation of MYD88L265P plasmablasts in vivoJames Q Wang, Bruce Beutler, Christopher C Goodnow, et al.
The Journal of Experimental Medicine|October 23, 2002
Analysis of an ethylnitrosourea-generated mouse mutation defines a cell intrinsic role of nuclear factor kappaB2 in regulating circulating B cell numbersLisa A Miosge, Julie Blasioli, Mathieu Blery, et al.
The Journal of Experimental Medicine|June 15, 2016
Clonal redemption of autoantibodies by somatic hypermutation away from self-reactivity during human immunizationJoanne H Reed, Jennifer Jackson, Daniel Christ, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2010
Consequences of increased CD45RA and RC isoforms for TCR signaling and peripheral T cell deficiency resulting from heterogeneous nuclear ribonucleoprotein L-like mutationZuopeng Wu, Adele L Yates, Gerard F Hoyne, et al.
Plos One|November 11, 2011
Differential requirement for the CD45 splicing regulator hnRNPLL for accumulation of NKT and conventional T cellsMehmet Yabas, Dale I Godfrey, Christopher C Goodnow, et al.
Pageof 19